Skip to main navigation Skip to search Skip to main content

Effect of MD1003 in progressive multiple sclerosis: a randomized double blind placebo controlled study

Project: Research

Project Details

StatusFinished
Effective start/end date01/9/1701/9/22

Funding

  • Parexel International LLC: $103,021.75